検索に戻る
案件記録

Cryoprotective Compositions, Surgical Kits, and Methods for Protection of a Surgical Site During Cryosurgery

発明審査中
1閲覧数
1請求項 · 1 独立
§ Ⅰ

案件概要

発明者

Franz Schmidlin; John Bischof; Paul A. Iaizzo; Qi Shao; Pegah Ranjbartehrani; David A. Ramirez; Alexandre Porcello

IPC分類

A61L 31/16A61B 18/A61B 18/2A61L 31/2A61L 31/4A61M 5/32

CPC分類

A61L31/16A61B18/2A61L31/28A61L31/42A61M5/3294A61B2018/101A61B2018/547A61L2300/216A61L2300/232A61L2400/6

A surgical kit for providing a cryoprotective composition configured to be applied during cryotreatment of a patient includes: a first container containing a predetermined amount or volume of a biodegradable and/or bioerodible fluid agent; and a second container containing a predetermined amount or volume of a non-toxic cryoprotectant agent. The predetermined amount or volume of the of biodegradable and/or bioerodible fluid agent and the predetermined amount or volume of a non-toxic cryoprotectant agent are configured to be mixed together to form the cryoprotective composition in which a therapeutically effective amount of the cryoprotective composition deposited in a body space of the patient in proximity to the cryotreatment remains within at least a portion of the body space for a duration of the cryotreatment and at least a portion of a body tissue proximate to the body space is viable after the cryotreatment.

原文(中国語)

A surgical kit for providing a cryoprotective composition configured to be applied during cryotreatment of a patient includes: a first container containing a predetermined amount or volume of a biodegradable and/or bioerodible fluid agent; and a second container containing a predetermined amount or volume of a non-toxic cryoprotectant agent. The predetermined amount or volume of the of biodegradable and/or bioerodible fluid agent and the predetermined amount or volume of a non-toxic cryoprotectant agent are configured to be mixed together to form the cryoprotective composition in which a therapeutically effective amount of the cryoprotective composition deposited in a body space of the patient in proximity to the cryotreatment remains within at least a portion of the body space for a duration of the cryotreatment and at least a portion of a body tissue proximate to the body space is viable after the cryotreatment.

外部リソース